Alane P Barnes Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Alane P Barnes is Chief Legal Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 412,729 shares of BCRX, which is worth approximately $3.14 Million. The most recent transaction as insider was on Dec 19, 2024, when has been sold 2,461 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $18,186. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 413K

37.23% 3M change

40.6% 12M change

Total Value Held $3.14 Million

Alane P Barnes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2024	SELL Payment of exercise price or tax liability	$18,186 $7.39 p/Share	2,461 Reduced 0.59%	412,729 Common Stock
Dec 19 2024	BUY Grant, award, or other acquisition	-	120,700 Added 22.52%	415,190 Common Stock
Dec 14 2024	SELL Payment of exercise price or tax liability	$64,855 $7.53 p/Share	8,613 Reduced 2.84%	294,490 Common Stock
May 13 2024	BUY Open market or private purchase	$27,650 $5.53 p/Share	5,000 Added 1.64%	300,762 Common Stock
Dec 19 2023	SELL Payment of exercise price or tax liability	$15,016 $6.05 p/Share	2,482 Reduced 0.84%	293,539 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$25,816 $6.43 p/Share	4,015 Reduced 1.34%	296,021 Common Stock
Dec 14 2023	BUY Grant, award, or other acquisition	-	64,000 Added 17.58%	300,036 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	34,000 Added 12.75%	232,770 Common Stock
Dec 15 2022	SELL Open market or private sale	$45,424 $10.88 p/Share	4,175 Reduced 2.06%	198,770 Common Stock
Dec 14 2021	BUY Grant, award, or other acquisition	-	75,000 Added 25.26%	221,969 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$169,580 $4.73 p/Share	35,852 Added 19.7%	146,127 Common Stock
May 11 2021	SELL Open market or private sale	$1,237,471 $12.04 p/Share	102,780 Reduced 48.24%	110,275 Common Stock
May 11 2021	BUY Exercise of conversion of derivative security	$397,759 $3.87 p/Share	102,780 Added 32.54%	213,055 Common Stock
Dec 11 2020	SELL Open market or private sale	$109,378 $7.96 p/Share	13,741 Reduced 11.28%	108,061 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	$57,025 $4.15 p/Share	13,741 Added 10.14%	121,802 Common Stock
Dec 04 2020	SELL Open market or private sale	$85,606 $6.23 p/Share	13,741 Reduced 11.28%	108,061 Common Stock
Dec 04 2020	BUY Exercise of conversion of derivative security	$57,025 $4.15 p/Share	13,741 Added 10.14%	121,802 Common Stock

APB

Alane P Barnes

Chief Legal Officer

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account